Chemomab Presentation at H.C. Wainwright 27th Annual Global Investment Conference ...

ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan ...

Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors. Immuneering’s ...

The presentations at the Wells Fargo and Morgan Stanley conferences will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” ...

With two active production facilities, Kraig Labs has established parallel operations designed to ensure continuous rearing cycles of its specialized recombinant spider silk silkworms. This dual-site ...

Following these transactions, Mr. Matuszewski owns 1,145,362 shares of BioStem Technologies stock. For more information about the purchases, please visit the OTCID disclosure website HERE under ...

“Mountain Shot is a crafted experience infused with the natural complexities of mushrooms,” says Jessie Unruh, Director of Marketing for Breckenridge Distillery. “It is a toast to nature, friendship ...

Available webcasts will be accessible on Skye’s website.

Through this multi-phased transaction, BrainsWay aims to expand its long-term total addressable market.

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

Castle will also be available for one-on-one investor meetings during the Wells Fargo 20 th Annual Healthcare Conference on Sept. 4, 2025, and the 9 th Annual Lake Street Best Ideas Growth (BIG9) ...

ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the ...